Fundz

Navion Neurosciences reported raising $1.95 Million in an initial SEC Form D filing, from an offering of $5.1 Million

PRIVATESep 09, 2026$1.9M of $5.1M raised

Amount Raised

$1.95 Million

$1.95 Million sold, per SEC Form D (first sale Jun 10, 2026)
$10.8 Million per company press release (Sep 9, 2026)

Round Type

Seed

CharlottesvilleBiotechnologyHealth CareMedicalTherapeutics

Investors

Angelini LumiraAngelini Lumira Biosciences Fund

Description

Navion Neurosciences has successfully closed a $10.8 million Seed financing round. The capital will be used to advance their precision sodium-channel medicines aimed at treating epilepsy and neuropathic pain. This funding will support their research and development efforts. The round demonstrates strong investor confidence in Navion's innovative approach.

Quick answer

Navion Neurosciences raised $1.95 Million in a Seed round, dated September 9, 2026. Investors: Angelini Lumira and Angelini Lumira Biosciences Fund. Navion Neurosciences is based in Charlottesville, Virginia, United States.

How much did Navion Neurosciences raise?
Navion Neurosciences raised $1.95 Million in a Seed round on September 9, 2026.
Who invested in Navion Neurosciences?
Angelini Lumira and Angelini Lumira Biosciences Fund are named as investors in this round.
What does Navion Neurosciences do?
Navion Neurosciences is focused on developing precision sodium-channel medicines to treat epilepsy and neuropathic pain.
Where is Navion Neurosciences based and how big is it?
Navion Neurosciences is based in Charlottesville, Virginia, United States.

Source: Fundz verified event record.

Who else raised in Medical and Therapeutics around the same time

Companies in the same sectors as Navion Neurosciences that raised within 45 days of this round, from Fundz verified event records.

  • Tivic raised $8.4M (Series B) on October 8, 2026.
  • Rouge Therapeutics raised $58M (Series A) on October 6, 2026.
  • Omnio raised $3.3M (Seed) on October 2, 2026.
  • AvenCell Therapeutics raised $47M (Series C) on September 27, 2026.
  • Aqua Medical raised an undisclosed amount (Series B) on September 23, 2026.
  • Novadip Biosciences raised $12M (Convertible Note) on September 21, 2026.

Who to call at Navion Neurosciences, and when

A new round usually means Navion Neurosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Navion Neurosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Navion Neurosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Navion Neurosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Navion Neurosciences

Location

Charlottesville, Virginia, United States

About

Navion Neurosciences is focused on developing precision sodium-channel medicines to treat epilepsy and neuropathic pain. The company aims to advance innovative therapies that cater specifically to the needs of patients with these conditions. Their mission is to improve patient outcomes through targeted neurological treatments.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Navion Neurosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Navion Neurosciences's next move

See what Strategic adds

Navion Neurosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.